Actelion Settles With Generics Over Access to Drug Samples

, The Litigation Daily

   | 0 Comments

When does a branded drug maker have to turn over product samples to generic competitors? An antitrust battle between Actelion Pharmaceuticals and three of its generic rivals offered some clues, but the case settled Friday without providing a definitive answer.

What's being said

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article# 1202645242722

Thank you!

This article's comments will be reviewed.